ABSTRACT
INTRODUCTION

Donepezil is chemically (RS)-2-[(1-benzyl-4-piperidyl)
methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one. 1, 2 Donepezil hydrochloride (DH) is a specifi c and reversible inhibitor of acetylcholinesterase, and used in the treatment of Alzheimer's disease 3 ( Figure 1 ).
Literature review of DH reveals that ultraviolet (UV)-visible spectrophotometry method in tablet dosage form, 4 HPLC methods in tablets, 5, 6 HPLC methods in human plasma, 7 HPLC method in human and rat plasma, blood and microdialysates, 8 liquid chromatographymass spectrometry (LC-MS)-MS method, [9] [10] [11] HPTLC method in tablet dosage form 12 and enantiomers separation by HPLC method and its application in pharmacokinetics 13 methods were being reported for the estimation of DH in biological samples and in tablet dosage form.
However, there is no method reported till now for the estimation of DH in human plasma by spectrofl uorimetric method. The aim of this work was to develop a validated, sensitive, specifi c and simple, accurate, and time saving spectrofl uorimetric method for the determination of DH in human plasma.
MATERIALS AND METHODS
Instrument
Spectrofl uorimeter Model: FP-6500 PC series, Matched quartz cell (1 cm), Wavelength range: 220.00-750.00 nm, JASCO Japan.
Chemicals and reagents
API of DH was kindly gifted by INTAS Pharmaceuticals, Ahmedabad, Gujarat. Boric Acid, potassium chloride, sodium hydroxide, trichloroacetic acid (TCA), perchloric acid, N-Hexane, Iso-Propyl Alcohol, (AR Grade, S.D. Fine Chemicals Ltd., Mumbai, India) were used. Blank Human Plasma was kindly gifted by Prathma Blood Bank, Ahmedabad, Gujarat.
Glassware used in each procedure were soaked overnight in a chromic mixture (K 2 Cr 2 O 7 + concentrated H 2 SO 4 ), rinsed thoroughly with double distilled water and dried in dust-free air. Whatman fi lter paper no. 42 was used to fi lter the MEM solution to separate them from the precipitated proteins and debris.
Experimental
Preparation of standard stock solution of DH DH (25 mg) was accurately weighed and transferred to separate 25 mL volumetric fl asks. Dissolved in 10 mL double distilled water, sonicated for 10 min and volume made up to mark with double distilled water to obtain standard stock solution having concentration 1000 μg/mL. A volume of 5 mL aliquot from this solution transferred to 50 mL volumetric fl ask and volume made up with double distilled water to obtain working standard stock solution of 100 μg/mL.
Preparation of borate buffer pH (9.6) Boric acid (3.09 g) and potassium chloride (3.73 g) were accurately weighed and transferred to 250 mL volumetric fl ask. Volume was made up with distilled water. Then solution was transferred to 1000 mL beaker and pH of the solution adjusted to 9.6 by addition of 0.2 M of Sodium hydroxide solution. Then pH adjustment volume was made up 1000 mL with distilled water.
Extraction procedure
A volume of 500 μl of plasma sample was taken in 2 mL microcentrifuge tube, then 50 μl of drug solution was spiked and 500 μl of 5% TCA solution was added. It was centrifuged for 3 min at 5000 rpm, then supernatant was transferred in another 2 mL microcentrifuge tube and 100 μl of 0.1 N NaOH solution to make supernatant alkaline. To this microcentrifuge tube, 1 mL of 5 % IPA in n-Hexane solution was added and centrifuged for 3 min at 8000 rpm and upper organic phase was separated and remaining aqueous phase was again centrifuged with 1 mL 5% IPA in n-Hexane solution, and upper organic phase was separated and both organic phases were taken in 10 mL volumetric fl ask and evaporated to dryness. Then reconstituted with borate buffer to make up a volume of 10 mL and analyzed by spectrofl uorimeter.
Spectrofluorimetric condition
From the working standard solution, 1 μg/mL solution was prepared by appropriate dilution using diluent and scanned in the synchronous mode with a delta value 65 (medium sensitivity mode) from 220 to 680 nm. From the synchronous spectra of DH, 389 nm wavelength was selected for measurement of fl uorescence intensity of DH (Figure 2 ).
Method validation
Linearity
For preparation of calibration curve of DH, 500 μL of blank plasma was spiked with 50 μL of drug solutions of concentration of 1 μg/mL, 5 μg/mL, 9 μg/mL, 13 μg/mL, 17 μg/mL, and 21 μg/mL to get the fi nal concentration of 5 μg/mL, 25 μg/mL, 45 μg/mL, 65 μg/mL, 85 μg/mL, and 105 μg/mL, respectively. Then extraction was performed as discussed in extraction procedure and then fl uorescence intensity of prepared solutions was measured at emission wavelength of 389 nm.
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Precision Intra-day and inter-day precision was determined by measuring the fl uorescence intensity of DH 3 times within a day and on three different days, respectively. For intra-day and inter-day precision, intra-day precision 25, 65, 105 μg/mL were selected. 500 μL of blank plasma was spiked with 50 μL of drug solution of concentration of 5 μg/mL, 13 μg/mL, 21 μg/mL to get the fi nal concentration of 25 μg/mL, 65 μg/mL, and 105 μg/mL, respectively. Then extraction was performed as discussed in extraction procedure and then fl uorescence intensity of prepared solutions was measured at emission wavelength of 389 nm.
Recovery
A volume of 500 μL of blank plasma was spiked with 50 μL of drug solutions of concentration of 1 μg/mL, 5 μg/mL, 9 μg/mL, 13 μg/mL, 17 μg/mL, and 21 μg/mL to get the fi nal concentration of 5 μg/mL, 25 μg/mL, 45 μg/mL, 65 μg/mL, 85 μg/mL, and 105 μg/mL, respectively. Then extraction was performed as discussed in extraction procedure and then fl uorescence intensity of prepared solutions was measured at emission wavelength of 389 nm.
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Limit of detection and quantification (LOD and LOQ)
The sensitivity of the analytical method was evaluated by determining the LOD and LOQ. LOD and LOQ were calculated and reported using the following equation.
LOD= 3.3X σ/s and LOQ= 10X σ/s
Where, σ= standard deviation of the intercept and s= slope of the calibration curve.
RESULT AND DISCUSSION
Optimization of experimental conditions
Initially, extraction of DH was carried out with the help of protein precipitation by TCA. But their synchronous spectrum was exceeding the limit of fl uorescence intensity (1000 unit). Therefore, extraction of DH by only protein precipitation was not suffi cient for proposed method.
Hence, extraction of DH by protein precipitation followed by liquid-liquid extraction using 5% IPA in n-Hexane as extraction solvent was carried out. After this extraction, procedure good results were obtained for DH and no interference was observed from blank for estimation of DH. In addition, it also showed good recovery of drug from plasma.
Linearity
Linearity curve shows linearity in the range of 5-105 μg/mL for DH. The correlation coeffi cient (R 2 ) was found to be 0.9965 for DH, which indicates the method is linear. Linearity study of MEM is summarized in Table 1 .
Precision
Intra-day precision and inter-day precision for DH was performed by analyzing three different concentrations (μg/mL) within linearity ranges and percentage of relative standard deviation (%RSD) <10 shows that the method is precise. Results of intra-day and inter-day precision study are presented in Table 2 .
Recovery
Recovery study was performed by comparing the response of the drug extracted from spiked plasma with pure drug response, and %RSD was calculated, which shows the accuracy of the method. Summary of recovery study is depicted in Table 3 .
Summary of validation parameters for developed method is shown in Table 2 . 
